Aptamer-Based Monocyte Isolation Specificity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating or depleting monocytes and macrophages from biological samples are inefficient and lack specificity, which hinders their application in therapeutic and diagnostic processes.
Innovation Solution
Development of aptamer sequences that specifically bind to monocytes and macrophages, allowing for the isolation or depletion of these cells through targeted binding and separation techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional methods are used for isolating or depleting monocytes and macrophages, then the process can be performed with existing techniques, but the isolation efficiency and specificity are insufficient
Solution Approach 1:
The patent replaces conventional mechanical or physical separation methods with a biochemical recognition system. Aptamers are used as specific ligands that bind to surface markers on monocytes and macrophages, enabling selective isolation through biological recognition rather than mechanical separation. This substitution achieves both high specificity through molecular recognition and high efficiency through scalable biochemical processing.
Solution Approach 2:
The patent introduces aptamers as intermediary molecules that mediate the isolation process. These aptamers serve as specific mediators that recognize and bind to target cells (monocytes and macrophages) through their surface markers, facilitating selective separation. The aptamers act as a bridge between the isolation system and the target cells, enabling precise control over which cells are isolated or depleted.
2Reliability
If conventional isolation methods are used, then existing equipment and procedures can be utilized, but the availability of pure cell populations for therapeutic applications is limited
Solution Approach 1:
The patent replaces conventional mechanical separation techniques with aptamer-based biochemical recognition. This substitution enables obtaining highly pure cell populations suitable for therapeutic applications by using specific molecular recognition rather than physical separation, which often results in mixed cell populations.
Solution Approach 2:
The patent changes the isolation mechanism from physical/ mechanical parameters to biochemical parameters. By using aptamers with specific binding affinities for monocyte and macrophage surface markers, the system achieves precise control over cell population purity, ensuring therapeutic-grade purity levels that conventional methods cannot achieve.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of aptamers enables efficient and specific isolation or depletion of monocytes and macrophages, enhancing their availability for therapeutic applications and improving the accuracy of diagnostic methods.
Implementation Method 1
aptamer sequences that specifically bind to monocytes and/or macrophages
Data Source
AI summary
Provided herein are compositions comprising aptamers that specifically bind monocytes and/or macrophage and methods for their use. These aptamer compositions can be used in methods for isolating and/or enriching monocytes and/or macrophages or depleting cell populations of monocytes and/or macrophages. Further provided are methods of using the aptamers or cell populations generated using them in the methods disclosed herein for therapies and/or drug delivery.